Pae CU - Search Results

1

Patkar AA, Pae CU, Zarzar M. Patkar AA, et al. Among authors: pae cu. Drugs Today (Barc). 2007 Jun;43(6):361-77. doi: 10.1358/dot.2006.43.6.1050794. Drugs Today (Barc). 2007. PMID: 17612708 Review.

2

Selegiline transdermal system: current awareness and promise.

Pae CU, Lim HK, Han C, Neena A, Lee C, Patkar AA. Pae CU, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1153-63. doi: 10.1016/j.pnpbp.2007.04.020. Epub 2007 May 10. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17614182 Review.

3

Safety of selegiline transdermal system in clinical practice: analysis of adverse events from postmarketing exposures.

Pae CU, Bodkin JA, Portland KB, Thase ME, Patkar AA. Pae CU, et al. J Clin Psychiatry. 2012 May;73(5):661-8. doi: 10.4088/JCP.12m07648. J Clin Psychiatry. 2012. PMID: 22697192

4

Efficacy and safety of selegiline transdermal system (STS) for the atypical subtype of major depressive disorder: pooled analysis of 5 short-term, placebo-controlled trials.

Pae CU, Patkar AA, Jang S, Portland KB, Jung S, Nelson JC. Pae CU, et al. CNS Spectr. 2014 Aug;19(4):324-9. doi: 10.1017/S1092852913000655. Epub 2013 Oct 29. CNS Spectr. 2014. PMID: 24168807

5

A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.

Patkar AA, Masand PS, Pae CU, Peindl K, Hooper-Wood C, Mannelli P, Ciccone P. Patkar AA, et al. Among authors: pae cu. J Clin Psychopharmacol. 2006 Dec;26(6):653-6. doi: 10.1097/01.jcp.0000246212.03530.fd. J Clin Psychopharmacol. 2006. PMID: 17110825 Clinical Trial.

6

Paroxetine: current status in psychiatry.

Pae CU, Patkar AA. Pae CU, et al. Expert Rev Neurother. 2007 Feb;7(2):107-20. doi: 10.1586/14737175.7.2.107. Expert Rev Neurother. 2007. PMID: 17286545 Review.

7

Does minocycline have antidepressant effect?

Pae CU, Marks DM, Han C, Patkar AA. Pae CU, et al. Biomed Pharmacother. 2008 Jun;62(5):308-11. doi: 10.1016/j.biopha.2007.12.005. Epub 2008 Jan 14. Biomed Pharmacother. 2008. PMID: 18267354

8

Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence.

Pae CU, Serretti A, Patkar AA, Masand PS. Pae CU, et al. CNS Drugs. 2008;22(5):367-88. doi: 10.2165/00023210-200822050-00002. CNS Drugs. 2008. PMID: 18399707 Review.

9

An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features.

Pae CU, Masand PS, Peindl K, Mannelli P, Han C, Marks DM, Patkar AA. Pae CU, et al. Prim Care Companion J Clin Psychiatry. 2008;10(3):205-10. doi: 10.4088/pcc.v10n0305. Prim Care Companion J Clin Psychiatry. 2008. PMID: 18615172 Free PMC article.

10

Paroxetine: safety and tolerability issues.

Marks DM, Park MH, Ham BJ, Han C, Patkar AA, Masand PS, Pae CU. Marks DM, et al. Among authors: pae cu. Expert Opin Drug Saf. 2008 Nov;7(6):783-94. doi: 10.1517/14740330802423168. Expert Opin Drug Saf. 2008. PMID: 18983224 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

401 results

Search Page